Already positive, the research from RBC and its analyst Emma Letheren still consider the stock as a Buy opportunity. The target price remains set at EUR 70.
In his latest research note, analyst Emma Letheren confirms his negative recommendation. The broker RBC is keeping its Sell rating. The target price is unchanged at EUR 320.